{
  "company": {
    "name": "Bond Biosciences",
    "website": "https://bond.bio/",
    "record": "https://startuphistory.org/c/bond.bio"
  },
  "status": null,
  "history_since": "2021-12-10T10:38:29.000Z",
  "baseline": {
    "snapshot_id": "c0cf821a07ffe21a8a76b7e7b302f0400825700f90b45fdcf00f8cf0e0e72dd3",
    "observed_at": "2021-12-10T10:38:29.000Z",
    "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
    "description": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
    "evidence": "https://web.archive.org/web/20211210103829/https://bond.bio/",
    "evidence_kind": "internet_archive",
    "facts": {
      "version": 1,
      "pages": [
        {
          "page": "home",
          "customers": [],
          "investors": [],
          "prices": [],
          "compliance": [
            "FDA-APPROVED"
          ],
          "funding": []
        }
      ]
    },
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T12:06:20.482Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-05T12:06:20.482Z",
      "variants": [
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2021-12-10T10:38:29.000Z",
          "evidence": "https://web.archive.org/web/20211210103829/https://bond.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2023-09-27T03:06:20.000Z",
          "evidence": "https://web.archive.org/web/20230927030620/https://bond.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2024-01-05T04:50:55.000Z",
          "evidence": "https://web.archive.org/web/20240105045055/https://bond.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2024-09-14T04:47:51.000Z",
          "evidence": "https://web.archive.org/web/20240914044751/https://bond.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2025-02-08T03:11:39.000Z",
          "evidence": "https://web.archive.org/web/20250208031139/https://bond.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2025-11-15T14:09:42.000Z",
          "evidence": "https://web.archive.org/web/20251115140942/https://bond.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2025-12-02T19:42:47.000Z",
          "evidence": "https://web.archive.org/web/20251202194247/https://bond.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
          "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
          "observed_at": "2026-11-05T12:06:20.482Z",
          "evidence": "https://bond.bio/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Bond Biosciences | Therapeutics for Ion-Related Diseases",
      "subhead": "Bond Biosciences is an early-stage biopharmaceutical development company focused on the discovery and development of therapeutics that bind excess metal ions locally in the gastrointestinal (GI) tract",
      "from": "2021-12-10T10:38:29.000Z",
      "to": "2026-11-05T12:06:20.482Z",
      "captures": 8,
      "evidence": "https://bond.bio/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2021-12-10T10:38:29.000Z",
          "to": "2026-11-05T12:06:20.482Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Bond Biosciences” company record, https://startuphistory.org/c/bond.bio"
}